View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Cairn Homes Plc: Transaction in Own Shares

Cairn Homes Plc (CRN) Cairn Homes Plc: Transaction in Own Shares 22-May-2024 / 07:00 GMT/BST 22 May 2024   Cairn Homes plc (the “Company”) Transaction in own shares     The Company announces that on 21st of May 2024 it purchased a total of 100,000 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Goodbody Stockbrokers UC (“Goodbody”), as detailed below. The repurchased shares will be cancelled.     Euronext Dublin London Stock Exchange Number of o...

 PRESS RELEASE

LVMH Redefines Luxury Retail Experience in China with a new extended p...

EQS Newswire / 22/05/2024 / 08:00 CET/CEST PARIS, FRANCE - - 22 May 2024 - LVMH Group, the world leader in high-quality products, and Alibaba Group, the leading e-commerce and technology company in China, today announced an extended partnership to push further the boundary of luxury experience in China, leveraging Alibaba's cloud technologies, through AI-powered innovations in retail and on-line with Tmall. The deepened partnership is a strong commitment to the shared dedication of the two companies to pioneering retail innovation and delivering exceptional, tech-driven luxury experienc...

 PRESS RELEASE

Danske Bank A/S, ledende medarbejderes transaktioner

Danske Bank A/S, ledende medarbejderes transaktioner 22. maj 2024 Indberetning nr. 53/2024 Ændring i aktiebesiddelser hos Danske Banks indberetningspligtige i henhold til EU-forordningen om markedsmisbrug I forbindelse med Danske Bank A/S’ aktietilbagekøbsprogram sælger APMH Invest A/S løbende aktier i Danske Bank A/S pro rata. For yderligere detaljer henvises til de vedhæftede skemaer, hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres.   Kontakt: Stefan Singh Kailay, Head of Media...

 PRESS RELEASE

Danske Bank A/S, transactions by persons discharging managerial respon...

Danske Bank A/S, transactions by persons discharging managerial responsibilities 22 May 2024 Notification no. 53/2024 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back program in Danske Bank A/S, APMH Invest A/S continuously sells shares pro rata. For further details, please find the attached templates for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. Contact: Stef...

ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Alexander Krämer
  • Morten Larsen

Bold new targets

CMD succeeded in showing USD 80bn 2030 revenues as achievable. Conservative margin profile +2026 is the right signal to send. Long-term growth case supported by CMD, BUY.

ABGSC IT Research ... (+2)
  • ABGSC IT Research
  • Njål Kleiven
 PRESS RELEASE

KBC Group: Update regarding the KBC Group share buyback programme

KBC Group: Update regarding the KBC Group share buyback programme Within the framework of the share buyback programme announced on 10 August 2023 after trading hours, KBC Group NV wishes to advise that the following transactions took place on Euronext Brussels’ regulated market between 13 May 2024 and 17 May 2024, included: Date No. of shares Total price Average price Lowest price Highest price 13-05-2024 75 000 € 5 150 272 € 68.67 € 68.28 € 69.12 14-05-2024 75 000 € 5 164 020 € 68.85 € 68.24 € 69.18 15-05-2024 75 000 € 5 232 592 € 69.77 € 68.88 € 70.02 16-05-202...

 PRESS RELEASE

KBC Groupe: Mise à jour concernant le programme de rachat d’actions pr...

KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe Dans le cadre du programme de rachat d'actions propres, annoncé le 10 août 2023 hors séance boursière, KBC Groupe SA souhaite communiquer que les transactions suivantes ont eu lieu sur le marché réglementé de Euronext Bruxelles entre 13 mai 2024 et 17 mai 2024 inclus: DateNo. des actionsPrix totalPrix moyenPrix plus basPrix plus haut13-05-202475 000€ 5 150 272€ 68.67€ 68.28€ 69.1214-05-202475 000€ 5 164 020€ 68.85€ 68.24€ 69.1815-05-202475 000€ 5 232 592€ 69.77€ 68.88€ 70.0216-05-2024100 000€ 6 785 400...

 PRESS RELEASE

KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aand...

KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen In het kader van het inkoopprogramma voor eigen aandelen dat werd aangekondigd op 10 augustus 2023 na beurstijd, wenst KBC Groep te melden dat de volgende transacties plaatsvonden op de gereglementeerde markt van Euronext Brussel van 13 mei 2024 tot en met 17 mei 2024: Datum Aantal aandelen Totaalprijs Gemiddelde prijs Laagste prijs Hoogste prijs 13-05-2024 75 000 € 5 150 272 € 68.67 € 68.28 € 69.12 14-05-2024 75 000 € 5 164 020 € 68.85 € 68.24 € 69.18 15-05-2024 75 000 € 5 232 592 € 69.77 €...

 PRESS RELEASE

Transaction in own shares

Transaction in own shares OSB GROUP PLC                                        ISIN: GB00BLDRH36022 May 2024 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company announces that on 21 May 2024 it had purchased a total of 105,173 of its ordinary shares of £0.01 each (the "ordinary shares") on the London Stock Exchange, CBOE BXE, CBOE CXE and Aquis Exchange, through Jefferies International Limited as detailed below. The repurchased ordinary shares will be cancelled.  London Stock ExchangeCBOE BXECBOE CXEAquis ExchangeNumber of ordinary shares...

 PRESS RELEASE

GOGL – First Quarter 2024 Results

GOGL – First Quarter 2024 Results Golden Ocean Group Limited (NASDAQ/OSE: GOGL) (the “Company” or “Golden Ocean”), the world's largest listed owner of large size dry bulk vessels, today announced its unaudited results for the quarter ended March 31, 2024. Highlights Net income of $65.4 million and earnings per share of $0.33 (basic) for the first quarter of 2024, compared with net income of $57.5 million and earnings per share of $0.29 (basic) for the fourth quarter of 2023.Adjusted EBITDA of $114.3 million for the first quarter of 2024, compared with $123.2 mill...

 PRESS RELEASE

Equinor ASA: Share buy-back

Equinor ASA: Share buy-back Please see below information about transactions made under the second tranche of the 2024 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO). Date on which the second tranche of the 2024 programme was announced: 25 April 2024. The duration of the second tranche of the 2024 programme: 16 May to no later than 22 July 2024. Further information on the tranche can be found in the stock market announcement on its commencement dated 25 April 2024, available here: On 16 May 2024, Equinor ASA has purchased a total of 600,000 own sh...

 PRESS RELEASE

Equinor ASA: Tilbakekjøp av egne aksjer

Equinor ASA: Tilbakekjøp av egne aksjer Nedenfor følger informasjon om transaksjoner foretatt under andre transje av Equinor ASAs (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO) tilbakekjøpsprogram for 2024. Dato for når andre transje av 2024-programmet ble annonsert: 25. april 2024. Varigheten til andre transje av 2024-programmet: 16. mai til senest 22. juli 2024. Ytterligere informasjon om transjen kan finnes i børsmelding om dens oppstart datert 25. april 2024, tilgjengelig her: Den 16. mai 2024, har Equinor ASA kjøpt tilbake totalt 600.000 egne aksjer til en gjennomsnittspris på NOK ...

 PRESS RELEASE

NANOBIOTIX fait le point sur ses résultats financiers et opérationnel...

NANOBIOTIX fait le point sur ses résultats financiers et opérationnels du premier trimestre 2024 PARIS et CAMBRIDGE, Mass., 22 mai 2024 (GLOBE NEWSWIRE) -- (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur la physique pour élargir les possibilités de traitement des patients atteints de cancer, annonce aujourd’hui une mise à jour de ses progrès opérationnels et sa position de trésorerie pour le premier trimestre 2024. Résultats du premier trimestre 2024 Trésorerie et é...

 PRESS RELEASE

Arbutus to Present Imdusiran Data at EASL Congress 2024

Arbutus to Present Imdusiran Data at EASL Congress 2024 WARMINSTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that two abstracts have been accepted for poster and oral presentations at the European Association for the Study of the Liver (EASL) Congress 2024 taking place June 5 - 8, 2024 in Milan, Italy. The accepted abstracts for...

 PRESS RELEASE

GTT: Terms of availability of preparatory documents for the combined g...

GTT: Terms of availability of preparatory documents for the combined general meeting of shareholders on June 12, 2024 Terms of availability of preparatory documents for the combined general meeting of shareholders on June 12, 2024 Saint-Rémy-lès-Chevreuse – May 22, 2024. GTT (Gaztransport et Technigaz) informs its shareholders that the combined (ordinary and extraordinary) general meeting of shareholders will be held on Wednesday June 12, 2024 at 3:00 pm. The notice of meeting, including the agenda and the draft resolutions as well as the conditions and modalities of participation and vot...

 PRESS RELEASE

NANOBIOTIX Provides First Quarter 2024 Operational and Financial Updat...

NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update PARIS and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today provided an update on operational progress and reported financial results for the first quarter of 2024. First Quarter Financial Updates Cash and Cash Equivalents: Based on the current operating plan and financial projections, Nanobiotix anticipates that...

Synovus Financial Corp: 1 director

A director at Synovus Financial Corp sold/bought 51,539 shares at 40.023USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

United Bank Ltd: 3 directors

Two Directors at United Bank Ltd bought 200,000 shares at between 198.050PKR and 204.349PKR. The significance rating of the trade was 39/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...

ABGSC Renewable Energy Research ... (+3)
  • ABGSC Renewable Energy Research
  • Daniel Vårdal Haugland
  • John Olaisen
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch